Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$0.97 - $1.77 $11,054 - $20,170
11,396 New
11,396 $11,000
Q4 2021

Feb 14, 2022

SELL
$2.68 - $4.46 $201,648 - $335,579
-75,242 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$2.5 - $3.53 $72,752 - $102,726
-29,101 Reduced 27.89%
75,242 $248,000
Q2 2021

Aug 16, 2021

BUY
$2.36 - $3.2 $246,249 - $333,897
104,343 New
104,343 $307,000

Others Institutions Holding CKPT

About Checkpoint Therapeutics, Inc.


  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $299M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.